Innovative Paths - Company NewsBG Medicine

Press Releases

2010-07-13 BG Medicine Announces Peer-Reviewed Publication of The BioImage Study
2010-05-20 HRP Initiative to Make Available Biological Specimens, Imaging Studies, and Data from BioImage Study
2010-04-26 Inverness Medical and BG Medicine to Develop Galectin-3 Test for Inverness’ Triage® Meter
2010-03-08 BG Medicine and Abbott to Develop Galectin-3 Test for the i-STAT® System
2010-02-17 BG Medicine Collaborates with Merck on Development of Blood Test Related to Lipid Disorders
2010-02-16 BG Medicine Announces Peer-Reviewed Publication of Galectin-3 Study in Chronic Heart Failure
2010-01-29 BG Medicine Files Registration Statement for Proposed Initial Public Offering
2010-01-27 BG Medicine Announces Receipt of CE Mark for its Galectin-3 Blood Test
2009-11-17 Abbott to Develop New Heart Failure Test on ARCHITECT® Immunochemistry Diagnostics Platform
2009-08-06 Scientific Article Outlines Role of Galectin-3 in Heart Failure Development and Progression
2009-07-07 Humana and BG Medicine Enroll More than 6,800 Participants in BioImage Study Focused on Heart Attack
2009-03-31 BG Medicine Inc. launches Galectin-3 Website and Commences Galectin-3 Assay Service
2009-03-30 Cordex Pharma to Collaborate with BG Medicine in a Clinical Study of Heart Failure Biomarkers
2009-03-19 Peter Gardiner appointed Vice President, Medical Affairs and Senior Medical Officer
2009-03-12 NHLBI, Boston University Form New Collaboration with BG Medicine
2009-03-03 BG Medicine Appoints Doug White as Executive Vice President & General Manager, Diagnostics
2008-10-20 Carol Adiletto Appointed Vice President, Clinical and Regulatory Affairs
2008-07-24 BG Medicine Announces Publication of Biomarker Signature of Atherosclerotic Plaque Rupture
2008-07-17 BG Medicine Closes $40 Million in Series D Financing
2008-04-01 Takeda Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque
2008-02-12 BG Medicine and Copenhagen General Population Study Initiate Biomarker Discovery
2008-02-05 BG Medicine Acquires Exclusive Commercial Rights to Biomarker of Vascular Plaque Rupture
2007-12-20 BioImage Study Seeks To Identify Individuals At High Risk Of Heart Attack Or Stroke
2007-09-18 Spinal Muscular Atrophy Foundation and BG Medicine Announce Collaboration
2007-05-23 BG Medicine Acquires Exclusive Rights to Biomarkers of Congestive Heart Failure from ACS Biomarker
2007-05-16 BG Medicine and Multiple Sclerosis Research Center of New York Announce Collaboration
2007-05-09 BG Medicine Forms Research Collaboration with M. D. Anderson Cancer Center
2007-02-21 Critical Path Liver Toxicity Biomarker Study to Commence with Seven Pharmaceutical Companies
2007-01-31 High-Risk Plaque (HRP)
2007-01-30 Leading Healthcare Companies Join in Major R&D Effort to Prevent Heart Attack & Stroke
2007-01-16 BG Medicine & Applied Biosystems to Collaborate on Molecular Medicine Reseach
2006-08-11 Philips and BG Medicine Partner in Molecular Medicine for Early Detection and Monitoring of Disease
2006-08-11 Philips and BG Medicine Form Alliance for Molecular Medicine Research and Development
2006-04-24 DNage, Loders Croklaan, BG Medicine and Erasmus MC Announce Collaborative in Field of T2DM
2006-03-29 FDA's Accomplishments in 2005
2006-03-28 BG Medicine to Conduct Joint Biomarker Discovery Study for Muscle Toxicity with Mitsubishi Pharma Co
2006-02-21 TB Alliance and BG Medicine Initiate Biomarker Discovery Program
2006-01-13 FDA Rules Aim to Speed Drug Tests and Trim Costs
2005-12-22 BG Medicine Announces Article in Nature Reviews - Drug Discovery; Describes Role of Systems Biology
2005-11-18 Two Leading Researchers Named to Scientific Advisory Committee for Liver Toxicology Study
2005-11-16 BG Medicine to Present at ISRTP Workshop: Progress and Barriers to Incorporating Alternative Toxicol
2005-10-25 BG Medicine and FDA to Conduct Joint Biomarker Discovery Study to Improve Prediction of Human Liver
2005-09-09 MASS High Tech - New digs, direction for BG Medicine
2005-07-28 BG Medicine Announces Agreement with Boehringer Ingelheim Pharmaceuticals, Inc.
2005-05-19 BG Medicine Completes Relocation to Accommodate Growth
2005-03-10 BG Medicine to Present at the SG Cowen 25th Annual Health Care Conference
2005-03-07 BG Medicine Participates as a Member of the “21st Century FDA Task Force”.
2005-02-03 Beyond Genomics Becomes BG Medicine, Appoints Pieter Muntendam, MD President
2004-06-15 Beyond Genomics Appoints Stephen Martin as Senior VP & CTO
2004-03-02 Beyond Genomics Appoints Stelios Papadopoulos
2004-02-03 Beyond Genomics and AstraZeneca to apply Systems Biology to Toxicology Study
2004-01-28 Beyond Genomics & GlaxoSmithKline Announce Partnership to Apply Systems Biology to Metabolic Disease